Healthcare & Biotech

Provo, Utah – September 19, 2026 -- Canary Speech has been named to TIME and Statista's World's Top HealthTech Companies 2026 ranking, marking the second consecutive year the vocal biomarker technology firm has received the distinction.

TIME and Statista select 500 companies from thousands of HealthTech firms reviewed globally

The ranking evaluated companies across three primary data sources: Financial Performance Metrics, Reputation Analysis, and Online Engagement. The list was announced on September 17, 2026, and published on Time.com.

Aurora, Colo. – September 19, 2026 -- A new study from the University of Colorado Anschutz Marcus Institute for Brain Health finds that irritability following chronic mild traumatic brain injury (mTBI) in military veterans stems from a combination of PTSD symptoms, chronic pain and difficulty understanding speech in noisy environments, not a single psychological cause.

Study of 124 veterans links irritability to three distinct factors

Published in the Journal of Neuropsychiatry and Clinical Neurosciences, the research examined 124 military veterans, including 61 with chronic mTBI and 63 without any history of brain injury. Participants underwent standardized assessments measuring irritability, PTSD symptoms, chronic pain, balance and auditory processing, including speech-in-noise comprehension.

Shanghai – September 19, 2026 -- 111, Inc. (NASDAQ: YI) reported a net loss of RMB31.7 million (US$4.7 million) for the second quarter of 2026, more than four times the RMB7.3 million loss posted a year earlier, as the Shanghai-based healthcare platform accelerated its shift away from an asset-heavy distribution model.

Net revenue falls 28.3% as company sheds underperforming subsidiaries

Net revenue totaled RMB2.3 billion (US$339.0 million), down from RMB3.2 billion in the prior-year quarter. The company attributed the decline to last year's divestiture of several underperforming subsidiaries, part of a strategy to generate more service-based commission income and reduce operational and capital risk.

Geneva – September 19, 2026 -- MindMaze Therapeutics (SIX: MMTX) will launch MindMotion Lite by the end of 2026, a tablet-based neurorehabilitation device designed to cut home deployment costs and expand access to intensive stroke and neurological therapy outside clinical settings.

Tablet format replaces bulky hardware for home use

MindMotion Lite delivers the full range of neurotherapeutic activities currently available on the company's MindMotion GO system through a tablet interface, reducing the hardware footprint required for in-home deployment. The device retains full-body rehabilitation training capacity while streamlining the user experience for patients managing therapy at home. It also supports teleconsultation and remote management, allowing clinicians to monitor and adjust treatment plans as patients continue therapy beyond the clinic.

Sheridan, Wyo. – September 19, 2026 -- The global diagnostic imaging market will expand from $26.5 billion in 2026 to $33.2 billion by 2031, a 4.6% compound annual growth rate, according to a new study by Wissen Research.

AI moves inside the scanner, cutting exam times sharply

Deep learning reconstruction algorithms are now embedded directly into image acquisition pipelines rather than applied after scanning. GE HealthCare's Sonic DL sequence allows complex multi-sequence brain and joint MRI protocols to complete in under 15 minutes, letting hospitals raise per-scanner throughput without new capital equipment. Radiology remains the top specialty for AI device clearances, with more than 1,100 cleared by the U.S. FDA to date.

Washington – September 18, 2026 -- More than 20,100 Americans signed a petition in just four days demanding Congress reauthorize the Accelerating Access to Critical Therapies (ACT) for ALS law before its September 30, 2026 expiration date.

Petition drive targets key congressional committees ahead of deadline

The campaign, organized by advocacy group I AM ALS during its annual Week of Impact, directs the petition at Senate HELP Committee and House Energy and Commerce Committee leadership. Signatories include patients living with ALS, caregivers, researchers, and clinicians who rely on programs the law established.

Washington – September 18, 2026 -- First Health Advisory has launched Resilience360, a consulting program designed to validate whether hospitals and health systems can keep clinical operations running during cyberattacks, technology outages, third-party failures, and natural disasters.

Program targets the gap between disaster recovery plans and actual clinical continuity

Healthcare organizations have invested heavily in disaster recovery, incident response, and emergency preparedness, but many have not validated how clinical and operational workflows will continue functioning while systems are being restored, according to First Health Advisory. Resilience360 is built to close that gap by testing the people, processes, and workflows required to sustain patient care throughout a disruption, rather than adding another compliance framework.

Austin, Texas – September 18, 2026 -- Bambu Lab has launched a global design challenge on MakerWorld with seven accessibility organizations, issuing 24 design briefs between September and December 2026 that ask makers to produce 3D-printable aids for people with disabilities.

MakerWorld mobilizes its designer community around specific disability needs

The challenge marks the first time MakerWorld, described as the world's largest community of 3D-printing makers, has organized its designers around concrete briefs tied to named individuals and documented daily obstacles. Partner organizations include Ayúdame3D, the Emerging Tech Lab at Rancho Los Amigos National Rehabilitation Center, e-NABLE France, MakeGood, Makers Making Change (Neil Squire Society), PrintLab, and Rightfooted Foundation International.

Singapore – September 18, 2026 -- KELLS' AI Dental Scan has become the first AI-powered dental screening tool registered as a Class B medical device by Singapore's Health Sciences Authority (HSA) for direct consumer use, the company announced.

HSA registration validates KELLS' proprietary AI for at-home dental screening

The clearance allows users to capture smartphone images of their teeth, which KELLS' AI then analyzes to flag potential oral health concerns and indicate when professional dental care may be warranted. The registration marks a regulatory first for consumer-facing dental AI tools in Singapore and supports the company's expansion in the market.

Boston – September 18, 2026 -- Three Harvard University students have won the U.S. National title at the James Dyson Award 2026 for Rumble Rims, an infrared eye-tracking headset designed to screen young athletes for possible concussions in about 60 seconds. Radhika Saran, Cleo Pontone, and Sophia DeVito take home $6,500 in national prize money to fund further development of the device.